​

Biodesix (BDSX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BDSX Stock Forecast

Biodesix (BDSX) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $3.00, with a high of $3.00 and a low of $3.00. This represents a 867.74% increase from the last price of $0.31.

High: $3 Avg: $3 Low: $3 Last Closed Price: $0.31

BDSX Stock Rating

Biodesix stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (71.43%), 2 Hold (28.57%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 2 5 Strong Sell Sell Hold Buy Strong Buy

BDSX Price Target Upside V Benchmarks

TypeNameUpside
StockBiodesix867.74%
SectorHealthcare Stocks 26.39%
IndustryDiagnostics & Research Stocks19.16%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$3.00
Last Closing Price$0.31$0.31$0.31
Upside/Downside--867.74%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 25141--6
Jun, 25141--6
May, 2515---6
Apr, 2515---6
Mar, 2515---6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 16, 2024Sung Ji NamScotiabank$3.00$1.8264.84%867.74%
Jul 26, 2024Bill BonelloCraig-Hallum$3.00$1.6878.57%867.74%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 14, 2025Lake StreetBuyBuyhold
May 14, 2025William BlairMarket Performdowngrade
Sep 16, 2024ScotiabankOutperforminitialise
Jul 26, 2024Craig-HallumBuyinitialise
May 13, 2024Cowen & Co.Buyinitialise

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.37$-1.63$-1.91$-0.64$-0.33----
Avg Forecast$-1.28$-1.58$-1.44$-0.66$-0.35$-0.22$-0.15$-0.08$-0.01
High Forecast$-1.25$-1.54$-1.40$-0.64$-0.34$-0.21$-0.12$-0.07$-0.01
Low Forecast$-1.32$-1.62$-1.50$-0.68$-0.37$-0.23$-0.18$-0.08$-0.01
Surprise %7.03%3.16%32.64%-3.03%-5.71%----

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$45.56M$54.51M$38.21M$49.09M$71.32M----
Avg Forecast$33.42M$54.68M$39.31M$50.14M$70.78M$93.11M$115.37M$130.00M$155.70M
High Forecast$34.18M$55.93M$40.45M$50.31M$73.33M$94.49M$116.16M$132.35M$161.32M
Low Forecast$32.87M$53.79M$38.45M$49.97M$68.96M$91.73M$114.58M$127.65M$151.69M
Surprise %36.32%-0.33%-2.79%-2.09%0.77%----

Net Income Forecast

$-150M $-120M $-90M $-60M $-30M $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-36.47M$-44.48M$-80.39M$-52.15M$-42.93M----
Avg Forecast$-105.09M$-129.50M$-118.64M$-53.84M$-28.84M$-17.91M$-12.59M$-6.20M$-821.13K
High Forecast$-102.85M$-126.75M$-115.27M$-52.19M$-27.69M$-17.20M$-10.07M$-5.95M$-793.63K
Low Forecast$-108.20M$-133.34M$-123.12M$-55.50M$-29.99M$-18.63M$-15.11M$-6.45M$-859.64K
Surprise %-65.29%-65.65%-32.24%-3.15%48.85%----

BDSX Forecast FAQ

Is Biodesix stock a buy?

Biodesix stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Biodesix is a favorable investment for most analysts.

What is Biodesix's price target?

Biodesix's price target, set by 7 Wall Street analysts, averages $3 over the next 12 months. The price target range spans from $3 at the low end to $3 at the high end, suggesting a potential 867.74% change from the previous closing price of $0.31.

How does Biodesix stock forecast compare to its benchmarks?

Biodesix's stock forecast shows a 867.74% upside, outperforming the average forecast for the healthcare stocks sector (26.39%) and outperforming the diagnostics & research stocks industry (19.16%).

What is the breakdown of analyst ratings for Biodesix over the past three months?

  • July 2025: 16.67% Strong Buy, 66.67% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.
  • June 2025: 16.67% Strong Buy, 66.67% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 16.67% Strong Buy, 83.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Biodesix’s EPS forecast?

Biodesix's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.22, marking a -33.33% decrease from the reported $-0.33 in 2024. Estimates for the following years are $-0.15 in 2026, $-0.08 in 2027, and $-0.01 in 2028.

What is Biodesix’s revenue forecast?

Biodesix's average annual revenue forecast for its fiscal year ending in December 2025 is $93.11M, reflecting a 30.55% increase from the reported $71.32M in 2024. The forecast for 2026 is $115.37M, followed by $130M for 2027, and $155.7M for 2028.

What is Biodesix’s net income forecast?

Biodesix's net income forecast for the fiscal year ending in December 2025 stands at $-17.913M, representing a -58.28% decrease from the reported $-42.931M in 2024. Projections indicate $-12.59M in 2026, $-6.2M in 2027, and $-821K in 2028.